» Articles » PMID: 20583981

Modifying Radiation Damage

Overview
Specialty Pharmacology
Date 2010 Jun 30
PMID 20583981
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation leaves a fairly characteristic footprint in biological materials, but this is rapidly all but obliterated by the canonical biological responses to the radiation damage. The innate immune recognition systems that sense "danger" through direct radiation damage and through associated collateral damage set in motion a chain of events that, in a tissue compromised by radiation, often unwittingly result in oscillating waves of molecular and cellular responses as tissues attempt to heal. Understanding "nature's whispers" that inform on these processes will lead to novel forms of intervention targeted more precisely towards modifying them in an appropriate and timely fashion so as to improve the healing process and prevent or mitigate the development of acute and late effects of normal tissue radiation damage, whether it be accidental, as a result of a terrorist incident, or of therapeutic treatment of cancer. Here we attempt to discuss some of the non-free radical scavenging mechanisms that modify radiation responses and comment on where we see them within a conceptual framework of an evolving radiation-induced lesion.

Citing Articles

Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers.

Salama V, Geng Y, Rigert J, Fuller C, Shete S, Moreno A Clin Transl Radiat Oncol. 2023; 43:100669.

PMID: 37954025 PMC: 10634655. DOI: 10.1016/j.ctro.2023.100669.


Evaluation of Novel Tranexamic Acid/Montmorillonite Intercalation Composite, as a New Type of Hemostatic Material.

Ma F, Sui S, Yang Z, Ye T, Yang L, Han P Biomed Res Int. 2022; 2022:3963681.

PMID: 35265711 PMC: 8901336. DOI: 10.1155/2022/3963681.


Classes of Drugs that Mitigate Radiation Syndromes.

Micewicz E, Damoiseaux R, Deng G, Gomez A, Iwamoto K, Jung M Front Pharmacol. 2021; 12:666776.

PMID: 34084139 PMC: 8167044. DOI: 10.3389/fphar.2021.666776.


Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight.

McLaughlin M, Donoviel D, Jones J Aerosp Med Hum Perform. 2017; 88(7):665-676.

PMID: 28641684 PMC: 5937128. DOI: 10.3357/AMHP.4735.2017.


Potent radioprotective effects of combined regimens of famotidine and vitamin C against radiation-induced micronuclei in mouse bone marrow erythrocytes.

Zangeneh M, Mozdarani H, Mahmoudzadeh A Radiat Environ Biophys. 2015; 54(2):175-81.

PMID: 25634516 DOI: 10.1007/s00411-015-0586-5.


References
1.
Kagimoto O, Naganuma A, Imura N, Toge T, Niwa O, YOKORO K . Effect of the administration of bismuth nitrate on radiogenic thymoma induction in mice. J Radiat Res. 1991; 32(4):417-28. DOI: 10.1269/jrr.32.417. View

2.
Falk M, Lukasova E, Kozubek S . Chromatin structure influences the sensitivity of DNA to gamma-radiation. Biochim Biophys Acta. 2008; 1783(12):2398-414. DOI: 10.1016/j.bbamcr.2008.07.010. View

3.
Neta R, Oppenheim J, Wang J, Snapper C, Moorman M, Dubois C . Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. J Immunol. 1994; 153(4):1536-43. View

4.
Kusch T, Florens L, MacDonald W, Swanson S, Glaser R, Yates 3rd J . Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science. 2004; 306(5704):2084-7. DOI: 10.1126/science.1103455. View

5.
Nagata K, Iwasaki Y, Yamada T, Yuba T, Kono K, Hosogi S . Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respir Med. 2006; 101(4):800-7. DOI: 10.1016/j.rmed.2006.07.017. View